Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

839 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling.
Takata R, Katagiri T, Kanehira M, Tsunoda T, Shuin T, Miki T, Namiki M, Kohri K, Matsushita Y, Fujioka T, Nakamura Y. Takata R, et al. Among authors: namiki m. Clin Cancer Res. 2005 Apr 1;11(7):2625-36. doi: 10.1158/1078-0432.CCR-04-1988. Clin Cancer Res. 2005. PMID: 15814643 Clinical Trial.
Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.
Tamura K, Furihata M, Tsunoda T, Ashida S, Takata R, Obara W, Yoshioka H, Daigo Y, Nasu Y, Kumon H, Konaka H, Namiki M, Tozawa K, Kohri K, Tanji N, Yokoyama M, Shimazui T, Akaza H, Mizutani Y, Miki T, Fujioka T, Shuin T, Nakamura Y, Nakagawa H. Tamura K, et al. Among authors: namiki m. Cancer Res. 2007 Jun 1;67(11):5117-25. doi: 10.1158/0008-5472.CAN-06-4040. Cancer Res. 2007. PMID: 17545589
Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population.
Matsuda K, Takahashi A, Middlebrooks CD, Obara W, Nasu Y, Inoue K, Tamura K, Yamasaki I, Naya Y, Tanikawa C, Cui R, Figueroa JD, Silverman DT, Rothman N, Namiki M, Tomita Y, Nishiyama H, Kohri K, Deguchi T, Nakagawa M, Yokoyama M, Miki T, Kumon H, Fujioka T, Prokunina-Olsson L, Kubo M, Nakamura Y, Shuin T. Matsuda K, et al. Among authors: namiki m. Hum Mol Genet. 2015 Feb 15;24(4):1177-84. doi: 10.1093/hmg/ddu512. Epub 2014 Oct 3. Hum Mol Genet. 2015. PMID: 25281661 Free PMC article.
Prospective study of combined treatment with interferon-alpha and active vitamin D3 for Japanese patients with metastatic renal cell carcinoma.
Obara W, Mizutani Y, Oyama C, Akaza H, Ishii N, Kohri K, Namiki M, Okuyama A, Shima H, Yokoyama M, Shuin T, Miki T, Watanabe Y, Fujioka T. Obara W, et al. Among authors: namiki m. Int J Urol. 2008 Sep;15(9):794-9. doi: 10.1111/j.1442-2042.2008.02086.x. Epub 2008 Jul 10. Int J Urol. 2008. PMID: 18651865 Clinical Trial.
Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen.
Miyanaga N, Akaza H, Hinotsu S, Fujioka T, Naito S, Namiki M, Takahashi S, Hirao Y, Horie S, Tsukamoto T, Mori M, Tsuji H. Miyanaga N, et al. Among authors: namiki m. Cancer Sci. 2012 Jan;103(1):125-30. doi: 10.1111/j.1349-7006.2011.02120.x. Epub 2011 Nov 9. Cancer Sci. 2012. PMID: 21988617 Free PMC article. Clinical Trial.
Bladder compliance in patients with benign prostatic hyperplasia.
Yokoyama O, Mita E, Ishiura Y, Nakamura Y, Nagano K, Namiki M. Yokoyama O, et al. Among authors: namiki m. Neurourol Urodyn. 1997;16(1):19-27; discussion 28-9. doi: 10.1002/(sici)1520-6777(1997)16:1<19::aid-nau2>3.0.co;2-h. Neurourol Urodyn. 1997. PMID: 9021787
839 results